Lucid Diagnostics Inc stock is traded at $0.3814, with a volume of 1,746,410. It is down -4.65% in the last 24 hours and down -36.16% over the past month. Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Previous Close:
$0.4
Open:
$0.41
24h Volume:
1,746,410
Relative Volume:
0.82
Market Cap:
$72.83M
Revenue:
$4.71M
Net Income/Loss:
-$58.01M
P/E Ratio:
-
EPS:
-$0.8234
Net Cash Flow:
-$46.68M
1W Performance:
-2.23%
1M Performance:
-36.16%
6M Performance:
-63.33%
1Y Performance:
-65.64%
1-Day Range:
$0.3731$0.42
1-Week Range:
$0.3731$0.4295
52-Week Range:
$0.303$1.63
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics IncSector
HealthcareIndustry
Medical DevicesPhone
212 949 4319Address
360 MADISON AVENUE, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS